勘误：骨形态发生蛋白4通过抑制NLRP3炎性小体激活和上皮-间质转化改善博来霉素诱导的小鼠肺纤维化。
Erratum: Bone morphogenetic protein 4 ameliorates bleomycin-induced pulmonary fibrosis in mice by repressing NLRP3 inflammasome activation and epithelial-mesenchymal transition.
出版信息
J Thorac Dis. 2025 Mar 31;17(3):1788-1789. doi: 10.21037/jtd-2025b-06. Epub 2025 Mar 27.
Abstract
[This corrects the article DOI: 10.21037/jtd-23-1947.].
摘要
[本文更正文章DOI：10.21037/jtd-23-1947。]
相似文献
1
Erratum: Bone morphogenetic protein 4 ameliorates bleomycin-induced pulmonary fibrosis in mice by repressing NLRP3 inflammasome activation and epithelial-mesenchymal transition.勘误：骨形态发生蛋白4通过抑制NLRP3炎性小体激活和上皮-间质转化改善博来霉素诱导的小鼠肺纤维化。
J Thorac Dis. 2025 Mar 31;17(3):1788-1789. doi: 10.21037/jtd-2025b-06. Epub 2025 Mar 27.
2
Bone morphogenetic protein 4 ameliorates bleomycin-induced pulmonary fibrosis in mice by repressing NLRP3 inflammasome activation and epithelial-mesenchymal transition.骨形态发生蛋白4通过抑制NLRP3炎性小体激活和上皮-间质转化改善博来霉素诱导的小鼠肺纤维化。
J Thorac Dis. 2024 Aug 31;16(8):4875-4891. doi: 10.21037/jtd-23-1947. Epub 2024 Aug 28.
3
NLRP3 Inflammasome Activates Endothelial-to-Mesenchymal Transition via Focal Adhesion Kinase Pathway in Bleomycin-Induced Pulmonary Fibrosis.NLRP3 炎性小体通过黏着斑激酶通路在博来霉素诱导的肺纤维化中激活血管内皮细胞向间充质细胞转化。
Int J Mol Sci. 2023 Oct 31;24(21):15813. doi: 10.3390/ijms242115813.
4
Iguratimod ameliorates bleomycin-induced pulmonary fibrosis by inhibiting the EMT process and NLRP3 inflammasome activation.依古比托改善博来霉素诱导的肺纤维化，是通过抑制 EMT 过程和 NLRP3 炎性小体激活。
Biomed Pharmacother. 2022 Sep;153:113460. doi: 10.1016/j.biopha.2022.113460. Epub 2022 Jul 25.
5
NecroX-5 ameliorates bleomycin-induced pulmonary fibrosis via inhibiting NLRP3-mediated epithelial-mesenchymal transition.NecroX-5 通过抑制 NLRP3 介导体上皮-间充质转化缓解博来霉素诱导的肺纤维化。
Respir Res. 2022 May 20;23(1):128. doi: 10.1186/s12931-022-02044-3.
6
Andrographolide alleviates bleomycin-induced NLRP3 inflammasome activation and epithelial-mesenchymal transition in lung epithelial cells by suppressing AKT/mTOR signaling pathway.穿心莲内酯通过抑制AKT/mTOR信号通路减轻博来霉素诱导的肺上皮细胞中NLRP3炎性小体激活和上皮-间质转化。
Ann Transl Med. 2021 May;9(9):764. doi: 10.21037/atm-20-7973.
7
NLRP3 inflammasome activation in alveolar epithelial cells promotes myofibroblast differentiation of lung-resident mesenchymal stem cells during pulmonary fibrogenesis.肺泡上皮细胞中 NLRP3 炎性小体的激活促进肺纤维化过程中肺固有间充质干细胞的成肌纤维细胞分化。
Biochim Biophys Acta Mol Basis Dis. 2021 May 1;1867(5):166077. doi: 10.1016/j.bbadis.2021.166077. Epub 2021 Jan 27.
8
Ginsenoside Rb1 Alleviates Bleomycin-Induced Pulmonary Inflammation and Fibrosis by Suppressing Central Nucleotide-Binding Oligomerization-, Leucine-Rich Repeat-, and Pyrin Domains-Containing Protein Three Inflammasome Activation and the NF-κB Pathway.人参皂苷 Rb1 通过抑制核苷酸结合寡聚化结构域、富含亮氨酸重复序列和 pyrin 结构域蛋白 3 炎症小体激活和 NF-κB 通路缓解博来霉素诱导的肺炎症和纤维化。
Drug Des Devel Ther. 2022 Jun 13;16:1793-1809. doi: 10.2147/DDDT.S361748. eCollection 2022.
9
Lycorine ameliorates bleomycin-induced pulmonary fibrosis via inhibiting NLRP3 inflammasome activation and pyroptosis.石蒜碱通过抑制 NLRP3 炎性小体激活和细胞焦亡减轻博来霉素诱导的肺纤维化。
Pharmacol Res. 2020 Aug;158:104884. doi: 10.1016/j.phrs.2020.104884. Epub 2020 May 16.
10
NLRP3 participates in the regulation of EMT in bleomycin-induced pulmonary fibrosis.NLRP3参与博来霉素诱导的肺纤维化中上皮-间质转化的调控。
Exp Cell Res. 2017 Aug 15;357(2):328-334. doi: 10.1016/j.yexcr.2017.05.028. Epub 2017 Jun 4.
本文引用的文献
1
Bone morphogenetic protein 4 ameliorates bleomycin-induced pulmonary fibrosis in mice by repressing NLRP3 inflammasome activation and epithelial-mesenchymal transition.骨形态发生蛋白4通过抑制NLRP3炎性小体激活和上皮-间质转化改善博来霉素诱导的小鼠肺纤维化。
J Thorac Dis. 2024 Aug 31;16(8):4875-4891. doi: 10.21037/jtd-23-1947. Epub 2024 Aug 28.
Zotero 插件